Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
5.01
+0.39 (8.44%)
At close: Jun 6, 2025, 4:00 PM
5.04
+0.03 (0.60%)
After-hours: Jun 6, 2025, 6:08 PM EDT

Monte Rosa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
308426283368950-
Upgrade
Market Cap Growth
-19.26%50.74%-23.21%-61.22%--
Upgrade
Enterprise Value
24228151142583-
Upgrade
Last Close Price
5.016.945.657.6120.42-
Upgrade
PS Ratio
2.495.64----
Upgrade
PB Ratio
1.121.911.581.362.73-
Upgrade
P/TBV Ratio
1.121.911.581.362.73-
Upgrade
P/FCF Ratio
10.1111.22----
Upgrade
P/OCF Ratio
8.8910.15----
Upgrade
EV/Sales Ratio
0.153.01----
Upgrade
EV/FCF Ratio
0.796.00----
Upgrade
Debt / Equity Ratio
0.150.190.260.17--
Upgrade
Debt / FCF Ratio
1.371.12----
Upgrade
Asset Turnover
0.480.20----
Upgrade
Quick Ratio
5.532.375.0010.5820.801.43
Upgrade
Current Ratio
5.612.405.0710.7920.961.49
Upgrade
Return on Equity (ROE)
2.88%-36.15%-60.07%-35.06%-40.35%-277.72%
Upgrade
Return on Assets (ROA)
-0.40%-13.66%-27.72%-19.82%-21.92%-57.90%
Upgrade
Return on Capital (ROIC)
-0.52%-20.65%-32.95%-21.09%-24.85%-131.69%
Upgrade
Earnings Yield
2.00%-17.05%-47.85%-29.46%-7.79%-
Upgrade
FCF Yield
9.89%8.91%-22.22%-28.61%-7.28%-
Upgrade
Buyback Yield / Dilution
-47.16%-43.80%-8.83%-88.91%-1548.09%-7.11%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q